Phase III Investigation of Neoadjuvant Carboplatin ± Veliparib in Combination With Chemotherapy in Early-Stage TNBC
Slideset - Addition of veliparib and carboplatin to neoadjuvant T→ AC did not increase pCR rate over carboplatin plus T→ AC alone.
Source: Clinical Care Options Breast Cancer - Category: Cancer & Oncology Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy